Updated:
NextWaveBio
NextWaveBio is a family office based in Shanghai, China, with secondary offices in Melville and East Harford in the United States.
NextWaveBio
NextWaveBio is a family office based in Shanghai, China, with secondary offices in Melville and East Harford in the United States. The firm's core investment focus spans biotechnology, healthcare services, and real estate, though its founding year and wealth origin remain undisclosed. NextWaveBio targets direct investments and co-investments across its stated sectors, with a geographic footprint covering Asia and North America. The firm is known to hold positions in biotechnology and healthcare services, often partnering with operators in these fields. Real estate investments likely include commercial and residential properties across its operating regions. The family office employs a lean team structure, with offices in three cities to cover its investment activities. No publicly available information exists on total professionals, assets under management, or team composition. The firm does not maintain a public website or social media presence, making its operations opaque. NextWaveBio's structural differentiator is its dual-region presence spanning China and the United States, which may provide cross-border deal flow and regulatory insights. However, the firm's limited public footprint makes it difficult to assess its governance, succession, or operating-company relationships.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Additional offices
Melville, United States · East Harford, United States
Sector focus
Frequently asked questions
What is NextWaveBio's primary investment focus?
NextWaveBio focuses on biotechnology, healthcare services, and real estate. The firm makes direct investments and co-investments across these sectors, with a geographic reach covering China and the United States (public record).
Where is NextWaveBio based?
NextWaveBio's main office is in Shanghai, China, with additional offices in Melville and East Harford in the United States. This tri-city footprint supports its cross-border investment activities (public record).
Does NextWaveBio invest in fund commitments or only direct deals?
Publicly available information suggests NextWaveBio pursues direct investments and co-investments. No evidence indicates it commits to external funds (public record).
How does NextWaveBio source deal flow?
Given the firm's opaque public presence, its sourcing model is not disclosed. The Shanghai and US offices may provide local networks for proprietary deal flow in biotechnology and healthcare (public record).
Is NextWaveBio a single-family office?
Based on available information, NextWaveBio appears to operate as a single-family office, given its closed structure and limited public disclosures (public record).
Who runs investment decisions at NextWaveBio?
The principals or investment team of NextWaveBio are not publicly disclosed. No named individuals appear in any sources (public record).
Does NextWaveBio maintain philanthropic structures?
No publicly available information indicates NextWaveBio operates philanthropic arms. The firm's structures beyond its investment activities remain opaque (public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: